Status:
NOT_YET_RECRUITING
Use of Different Enteral Feeds to Impact on Chyle Leaks in Oesophagectomy
Lead Sponsor:
Royal College of Surgeons, Ireland
Conditions:
Oesophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Oesophagectomy (surgery to remove a cancerous portion of the oesophagus or gullet) is the cornerstone of treating oesophageal cancer. In recent years, minimally invasive techniques, including robotic ...
Detailed Description
What is the purpose of the study? Oesophagectomy (surgery to remove a cancerous portion of the oesophagus or gullet) is the cornerstone of treating oesophageal cancer. In recent years, minimally invas...
Eligibility Criteria
Inclusion
- All adults aged over 18 years undergoing MIO or RAMIO for oesophageal cancer (adenocarcinoma and squamous cell cancer) at Beaumont Hospital will be approached for inclusion.
Exclusion
- Patients will be excluded if
- They are unable to provide informed consent
- They do not receive a feeding jejunostomy at or prior to their oesophagectomy
- Prior or concomitant malignancy that would interfere with this protocol
Key Trial Info
Start Date :
May 5 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06965205
Start Date
May 5 2025
End Date
December 31 2030
Last Update
May 11 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.